Logo

asset acquisition

Labcorp to Acquire Myriad Genetics' Vectra Rheumatoid Arthritis Test for $150M

The deal for the blood-based proteomic test, which measures disease activity in patients with rheumatoid arthritis, is expected to close in Q3 2021.

Immunai Using Acquisition, Funding to Shift Into Functional Work
Premium

The immune profiling company is looking to expand its functional genomics capabilities to more directly inform immune therapy development and application.

Immunai Acquires Dropprint Genomics

The acquisition gives Immunai access to Dropprint's computational tools and to its database of immune cell profiles from autoimmune and cancer patients.

Agilent Charges Into Liquid Biopsy Space with Resolution Bioscience Acquisition
Premium

The firm will build liquid biopsy companion diagnostic tests that complement its tissue-based assays and are tailored for drugs developed by pharma partners.

10x Genomics Acquires Denmark's Tetramer Shop

The acquisition, 10x Genomics' fifth, could boost the firm's offerings for immune cell detection and discovery.

Feb 17, 2021

Thermo Fisher Scientific Acquires Cell Sorting Technology From Propel Labs

Oct 14, 2020

10x Genomics Acquisitions Point Towards New In Situ Analyisis Platform
Premium

Oct 14, 2020

Summa Equity Acquires Proteomics Firm Sengenics

Oct 5, 2020

10x Genomics to Acquire ReadCoor for $350M, Cartana for $41.2M

Sep 30, 2020

Bruker Acquires Software Platform From Integrated Proteomics Applications

Jun 18, 2020

Illumina Acquires Informatics Firm BlueBee

Mar 4, 2020

Abcam Acquires Marker Gene Technologies

Feb 6, 2020

Quest Diagnostics Aims to Leverage Blueprint Acquisition to Advance Genetic Testing Portfolio
Premium

Jan 30, 2020

Abcam Acquires Applied StemCell Gene Editing Platform, Oncology Product Line

Dec 18, 2019

Rapid Diagnostics Resurrects Multiplex MiniLab Platform, Targets TB POC Test
Premium

Nov 22, 2019

Phenomics Health Acquires Precera Pharmacometabolomic Technology

Oct 25, 2019

Illumina Reserved in Comments on PacBio Deal, Forthcoming on Qiagen Deal and New Products
Premium

Oct 24, 2019

UK Regulators Propose Blocking $1.2B Illumina, PacBio Deal

Aug 15, 2019

GeneCentric Therapeutics Acquires Select ImmunoGenomics

Aug 6, 2019

Eurofins Genomics Buys Gene Synthesis Firm Blue Heron

Jul 16, 2019

Abcam Acquires Knockout Cell Lines, Lysates Portfolio From EdiGene

Jul 15, 2019

Interpace Dx Acquires Cancer Genetics' Biopharma Services

Jul 15, 2019

Evotec Acquires iPSC Drug-Discovery Assets From Ncardia

May 15, 2019

Ginkgo Bioworks Acquires Warp Drive Bio's Bioinformatics Platform

Apr 30, 2019

Caprion Biosciences Buys Immune Monitoring Firm Serametrix

Breaking News
The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.